HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Ophthalmology5 papers

Steroid-modified tinea infection

Last edited: 4/10/2026

Overview

Steroid-modified tinea infection refers to a fungal skin infection that has been altered by the use of topical or systemic corticosteroids. This modification can lead to atypical presentations and potentially more severe or widespread disease.

Diagnosis

  • Atypical clinical presentation of tinea infection, often with features of inflammation or scaling that are not typical for uncomplicated fungal infections.
  • Consider steroid-modified tinea in patients using topical steroids for a presumed inflammatory dermatosis that fails to improve or worsens 1.

    • Management

  • Discontinue topical or systemic steroids.
  • Initiate antifungal therapy.
  • Treatment typically involves topical or oral antifungal agents.

    • Key Recommendations

  • Discontinue the use of topical or systemic steroids when steroid-modified tinea infection is suspected 1. (Evidence: Expert opinion)
  • Initiate appropriate antifungal therapy after discontinuing steroid use. (Evidence: Expert opinion)

    • References

    1 Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatologic clinics 1992. link

    Original source

    1. [1]
      Ocular effects of topical and systemic steroids. — Renfro L, Snow JS Dermatologic clinics (1992)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG